Discounted Cash Flow Rating

Return on Equity Rating

Debt to Equity Rating

Price to Earnings Rating

Analyst Rating

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Strong Sell

D

EQRx, Inc. Warrant (EQRXW)

Pharmaceutical Preparations

https://www.eqrx.com

EQRx Inc is a biotechnology company. the company has more than 10 programs in its pipeline, including clinical, preclinical and drug engineering targets for the treatment of oncology and immune-inflammatory conditions. The program includes Aumolertinib, Lerociclib, Sugemalimab, Nofazinlimab, and others.

50 HAMPSHIRE STREET
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/20/2021

Market Cap

1,140,551,119

Shares Outstanding

482,960,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.0000

Last Div

0.0000

Range

0.0439-0.064

Chg

-0.0095

Avg Vol

N/A

Mkt Cap

1140551119

Exch

NASDAQ

Country

US

Phone

617 315 2255

DCF Diff

1.3063

DCF

1.0338

Div Yield

0.0000

P/S

0.0000

EV Multiple

-2.8509

P/FV

967.6985

Div Yield %

0.0000

P/E

-11746.6906

PEG

-46.3250

Payout

0.0000

Current Ratio

18.7751

Quick Ratio

18.4279

Cash Ratio

4.7985

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.4368

ROA

-0.0778

ROE

-0.0753

ROCE

-0.3371

NI/EBT

0.3706

EBT/EBIT

0.6575

EBIT/Rev

0.0000

Debt Ratio

0.0017

D/E

0.0018

LT Debt/Cap

0.0000

Total Debt/Cap

0.0018

Int Coverage

5.2521

CF/Debt

-160.2621

Equity Multi

1.0592

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.0007

FCF/Share

-0.0007

Cash/Share

0.0025

OCF/Sales

0.0000

FCF/OCF

1.0047

CF Coverage

-160.2621

ST Coverage

-160.2621

CapEx Coverage

-212.8562

Div&CapEx Cov

-212.8562

P/BV

967.6985

P/B

967.6985

P/S

0.0000

P/E

-11746.6906

P/FCF

-3.4386

P/OCF

-3432.1728

P/CF

-3432.1728

PEG

-46.3250

P/S

0.0000

EV Multiple

-2.8509

P/FV

967.6985

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation